Facebook Linkedin Twitter
Inside Precision Medicine Takeda Signs Deal Worth $2.2 Billion with AC Immune for Alzheimer’s Vaccine

Financial support

Nerve cells affected by Alzheimer's disease, which may involve abnormal microglia cells.
News & Features

Takeda Signs Deal Worth $2.2 Billion with AC Immune for Alzheimer’s Vaccine

0
3D Rendering of Antibody Drug Conjugate Molecules
News & Features

Enlaza Nets $100M to Advance Covalent Biologics Platform

0
Tech DNA
News & Features

Walgreens Dives into Gene and Cell Therapy Delivery

0
CART Cell Cancer Immunotherapy
News & Features

Precision Immuno-Oncology Start-Up Clasp Launches with $150M and Vogelstein as Co-Founder

0
crowd of all races and ethnicity
News & Features

NIH Awards Scripps Research $54M for Continuing Work on All of Us Research Program

0
tuberculosis (TB)
News & Features

Wellcome, Gates Foundation to Provide $550M to Fund Phase III TB Vaccine

0
Alzheimer's disease: illustration of the amyloid-beta 40 peptide (and others) accumulating to form amyloid fibrils that build up dense amyloid plaques.
Molecular Dx

Amyloid Disease Therapy, Diagnostics Developer AltPep Raises $53M in Series B Round

0
Clostridium bacteria, C. diff, illustration
Informatics

Delve Bio Launches with $35M Series A to Advance its Metagenomic Sequencing Platform for Infectious Disease Diagnosis

0
A conceptual illustration of Fatty liver cells in the shape of a liver to represent non-alcoholic fatty liver disease.
Informatics

Innovate UK Funds Collaboration to Find Undiagnosed Liver Disease Patients

0
Scientist holding a DNA sample with the results on a computer screen in a laboratory
Molecular Dx

Boundless Raises $100M in Series C to Fuel Extrachromosomal DNA Drug

0
123Page 1 of 3

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine